Skip to NavigationSkip to content

News

0
Top 10 news roundup
A number of new COVID-19 developments have emerged in April already: AstraZeneca has halted the trial of its COVID-19 vaccine on children amid blood-...
0
Cancer cell
Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first time ever.
0
Moderna have published antibody persistence data out to six months following the second dose of its COVID-19 vaccine (mRNA-1273) in The New England...
0
Results from Eli Lily and Incyte’s Phase III study, COV-BARRIER, evaluating baricitinib in the treatment of hospitalised COVID-19 patients did not...

Features

As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug pricing in the UK, how it...